DOMPE

Discover DOMPE: Italian pharmaceutical excellence

DOMPE is an Italian biopharmaceutical company founded in 1940 in Milan, specializing in the development and production of innovative medicines for the treatment of rare diseases and high therapeutic need. With over 80 years of experience, DOMPE stands out for its commitment to scientific research and the quality of its products.

Innovation and research at the heart of DOMPE

DOMPE has always placed scientific research at the center of its activities, developing advanced therapies thanks to cutting-edge technologies. The manufacturing and research center in L'Aquila, inaugurated in 1993, is the first in the world to produce recombinant human nerve growth factor, a protein discovered by Rita Levi-Montalcini that earned her the Nobel Prize.

Product range and commitment to quality

DOMPE offers a wide range of medicines, including Guaiacalcium, a historic cough remedy launched in 1940, and other products such as Artrosil and Tribenzoic. The company is certified ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018, ensuring high standards of quality and safety.